Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06102590

Oxygen Extraction-guided Transfusion

Oxygen Extraction-guided Transfusion Strategy in Critically Ill Patients. A Randomized Controlled Trial.

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
324 (estimated)
Sponsor
Università degli Studi di Ferrara · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

In critically ill patients, optimized strategies for red blood cells transfusion (RBCT) are still controversial. Most recent guidelines suggest that clinical practice in ICU setting should follow a restrictive approach to RBCT (i.e., hemoglonim level \< 7.0 g/dL).In our previous study, oxygen extraction ratio (O2ER) has shown good performance as a marker to identify the correct timing for RBCT, potentially affecting 90-day mortality in non-bleeding, critically ill patients \[11\]. Moreover, our data suggested that an individualized strategy for RBCT may reduce the incidence of acute kidney injury (AKI), which is possibly related to a better delivery of oxygen and organ perfusion.

Conditions

Interventions

TypeNameDescription
OTHERIndividualized red blood cell transfusion strategyPrescription of RCBT is restricted to patients who present Hb ≤ 9.0 g/dL and O2ER ≥ 30%.
OTHEREuropean guidelines red blood cell transfusion strategyRBCT according to ESICM guidelines

Timeline

Start date
2023-11-04
Primary completion
2026-11-01
Completion
2027-01-01
First posted
2023-10-26
Last updated
2025-07-31

Locations

4 sites across 2 countries: Belgium, Italy

Source: ClinicalTrials.gov record NCT06102590. Inclusion in this directory is not an endorsement.